Home›Stock Screener›Chandra Bhagat Pharma›Quarterly Results

Chandra Bhagat Pharma Quarterly Results

Latest Quarter Net Profit
₹3 Cr
QMarch 2026
Quarterly Results

Chandra Bhagat Pharma quarterly results. In 2026, Chandra Bhagat Pharma (CBPL) reported revenue ₹0 Cr and net profit ₹0 Cr. Review CBPL price earnings ratio to evaluate earnings-based valuation against sector peers.

CBPL Quarterly Results — Revenue, Profit & EPS Highlights

Chandra Bhagat Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Chandra Bhagat Pharma stock price NSE.

  • Revenue of ₹120 Cr in March 2026 (+0.0% vs March 2026, +30.4% vs March 2025)
  • Net Profit of ₹3 Cr in March 2026 (+0.0% vs March 2026, +200.0% vs March 2025)
  • EBITDA of ₹7 Cr in March 2026 (+0.0% vs March 2026)
  • Operating Margin of 3.0% in March 2026 (+0.0pp vs March 2026)
  • Earnings Per Share of ₹4.04 in March 2026 (+0.0% vs March 2026)

Chandra Bhagat Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

CBPL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2026 March 2025 March 2024 March 2023 QoQ YoY
Revenue (₹ Cr) 0 120 92 233 120 - -
Net Profit (₹ Cr) 0 3 1 2 1 - -
EBITDA (₹ Cr) 0 7 4 4 4 - -
EPS (₹) 0.00 4.04 1.14 2.03 1.20 - -
Operating Margin (%) 0.0% 3.0% 1.0% -3.0% 3.0% - -

CBPL Share Price Trend — 1-Year Movement Across Quarterly Results

Chandra Bhagat Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check CBPL market value to track the company's total market size over time.

Profitability Ratios

Profit Margin 2.5%
EBITDA Margin 5.8%
Operating Margin 3.0%
ROE (Annual) 9.1%

Balance Sheet Highlights

Total Assets ₹94 Cr
Total Equity ₹33 Cr
Current Assets ₹88 Cr
Current Liabilities ₹3 Cr

Cash Flow Analysis

Operating Cash Flow ₹9 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹-6 Cr
Net Cash Flow ₹3 Cr

Revenue Trend (₹ Cr)

March 2024 233
March 2025 92
March 2026 120
2026 0

Net Profit Trend (₹ Cr)

March 2024 2
March 2025 1
March 2026 3
2026 0

Operating Margin Trend (%)

March 2024 -3.0%
March 2025 1.0%
March 2026 3.0%
2026 0.0%

CBPL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Chandra Bhagat Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores